Infinity Pharmaceuticals Net Income Quarterly:
-46.98M for Dec. 31, 2012Infinity Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -46.98M |
| Sept. 30, 2012 | 18.40M |
| June 30, 2012 | -14.66M |
| March 31, 2012 | -10.72M |
| Dec. 31, 2011 | -14.06M |
| Sept. 30, 2011 | -11.94M |
| June 30, 2011 | -11.73M |
| March 31, 2011 | -2.306M |
| Dec. 31, 2010 | -14.04M |
| Sept. 30, 2010 | -20.95M |
| June 30, 2010 | -5.941M |
| March 31, 2010 | -8.055M |
| Dec. 31, 2009 | -6.678M |
| Sept. 30, 2009 | -9.326M |
| June 30, 2009 | -11.32M |
| March 31, 2009 | -3.950M |
| Dec. 31, 2008 | 46.77M |
| Sept. 30, 2008 | -12.39M |
| June 30, 2008 | -11.15M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
INFI Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | -64.67M |
| Clovis Oncology | -15.67M |
| Synageva BioPharma | -15.19M |
INFI Net Income Quarterly Rankings
| Overall |
32nd percentile 5115 of 7593 |
| Sector |
6th percentile 611 of 650 in Healthcare |
| Industry |
9th percentile 214 of 237 in Biotechnology |
INFI Net Income Quarterly Range, Past 5 Years
| Minimum | -46.98M | Dec 2012 |
| Maximum | 46.77M | Dec 2008 |
| Average | -7.949M |
